This webinar aims to provide an overview of Adaptive Biotechnologies’ immunoSEQ® Technology and cloud-based software, immunoSEQ Analyzer®. The webinar will cover functions of the Analyzer software and demonstrate how immunosequencing data can be incorporated into preclinical and clinical research with a focus on immuno-oncology and immunotherapy.
TORONTO (PRWEB) OCTOBER 31, 2019
Join Patrick Raber, PhD, Manager, Research and Business Development at Adaptive Biotechnologiesin a live webinar on Friday, November 15, 2019 at 1pm EST to learn about immunoSEQ Technology and its application in immuno-oncology.
Immunosequencing, the science of profiling T-cell receptors (TCRs) and B-cell receptors (BCRs), has been widely utilized to understand how the immune system changes in various disease states and how various treatment modalities impact immune responses. This webinar aims to provide an overview of Adaptive Biotechnologies’ immunoSEQ® Technology and cloud-based software, immunoSEQ Analyzer®. The webinar will cover functions of the Analyzer software and demonstrate how immunosequencing data can be incorporated into preclinical and clinical research with a focus on immuno-oncology and immunotherapy.
Other topics of discussion include:
- Specific examples of how immunoSEQ was used to assess repertoire properties in pre-treatment tumor biopsies and how those findings were correlated with survival and response to checkpoint blockade
- How the Analyzer software can identify individual clones and track those clones in longitudinal samples
- Overview of data on patients who demonstrated adverse events in response to immunotherapy treatment and the repertoire properties associated with those toxicities
- How immunosequencing may be used to identify dominant clones in cellular infusion products, along with appropriate sequencing strategies for monitoring
- Overview of Adaptive’s immuneACCESS® portal, a free, online database containing thousands of samples worth of human and murine data that can be easily analyzed and incorporated into existing or future immunoSEQ projects
For more information or to register for this event, visit Utilizing Immunosequencing in Immuno-Oncology and Immunotherapy Research.
immunoSEQ is Research Use Only. Not for use in diagnostic procedures.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.
Contact:
Candice Tang
Tel: +1 (416) 977-6555 ext 400
Email: [email protected]
Xtalks Life Science Webinars
Immunosequencing, the science of profiling T-cell receptors (TCRs) and B-cell receptors (BCRs), has been widely utilized to understand how the immune system changes in various disease states and how various treatment modalities impact immune responses
